Published in Orphanet J Rare Dis on October 30, 2006
Current views on the function of the lymphatic vasculature in health and disease. Genes Dev (2010) 1.84
Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period. Circ Res (2014) 0.90
Pediatric lymphangiectasia: an imaging spectrum. Pediatr Radiol (2014) 0.80
The fetal MR appearance of 'nutmeg lung': findings in 8 cases linked to pulmonary lymphangiectasia. Pediatr Radiol (2014) 0.79
Treatment of congenital pulmonary lymphangiectasia using ethiodized oil lymphangiography. J Perinatol (2014) 0.78
Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow. Am J Physiol Lung Cell Mol Physiol (2011) 0.78
CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes. Cardiol Young (2015) 0.76
Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol (2014) 0.76
Congenital generalized lymphangiectasia: a rare developmental disorder for non-immune fetal hydrops. Autops Case Rep (2015) 0.75
A Rare Case of Chylothorax due to Pulmonary Lymphangiectasia in a 7-Year-Old Boy. European J Pediatr Surg Rep (2013) 0.75
Intestinal lymphangiectasia in children. A favorable response to dietary modifications. Saudi Med J (2016) 0.75
Diagnosis of secondary pulmonary lymphangiectasia in congenital heart disease: a novel role for chest ultrasound and prognostic implications. Pediatr Radiol (2017) 0.75
Lymphangiogenesis in development and human disease. Nature (2005) 5.93
Octreotide. N Engl J Med (1996) 2.67
Lymphatic vasculature development. Nat Rev Immunol (2004) 2.33
The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc (1980) 2.01
Congenital pulmonary lymphangiectasis. Am J Dis Child (1970) 1.64
Images in clinical medicine. Congenital pulmonary lymphangiectasia. N Engl J Med (2003) 1.46
Molecular lymphangiogenesis: new players. Trends Cell Biol (2005) 1.42
Familial congenital non-immune hydrops, chylothorax, and pulmonary lymphangiectasia. Am J Med Genet A (2006) 1.41
Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol (2005) 1.25
Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg (1998) 1.25
Chylothorax in lymphangioleiomyomatosis. Chest (2003) 1.19
Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: a review. Am J Med Genet (2002) 1.17
Chylothorax in the neonatal period. Eur J Pediatr (1993) 1.14
Pulmonary lymphangiectasia: diagnosis and clinical course. Pediatr Pulmonol (2004) 1.13
Late presentation of primary pulmonary lymphangiectasis. Thorax (1978) 1.07
Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy. Pediatrics (2002) 1.05
Evaluation of a diagnostic approach to pediatric interstitial lung disease. Pediatrics (1998) 1.04
Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed (2003) 1.04
Congenital pulmonary lymphangiectasia: CT and pathologic findings. J Thorac Imaging (2004) 1.03
Congenital pulmonary lymphangiectasis with chylothorax: a heterogeneous lymphatic vessel abnormality. Am J Med Genet (1993) 1.02
[Surgery for chylothorax]. Rev Pneumol Clin (2004) 1.00
Pulmonary lymphangiectasia. Observation in 17 patients and proposed classification. Am J Roentgenol Radium Ther Nucl Med (1972) 0.97
Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR Am J Roentgenol (2000) 0.96
Primary pulmonary lymphangiectasia in infancy and childhood. Eur Respir J (2004) 0.95
Syndromic classification of hereditary lymphedema. Lymphology (2003) 0.95
Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum. Lymphology (2004) 0.94
Pulmonary lymphangiectasia revisited. J Pediatr Surg (2000) 0.93
Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am J Med Genet A (2003) 0.92
Successful octreotide treatment of chylous pleural effusion and lymphedema in the yellow nail syndrome. Ann Intern Med (2004) 0.90
Autopsy case of congenital pulmonary lymphangiectasis. Pathol Int (2004) 0.88
Octreotide for therapy of chylous ascites in yellow nail syndrome. Gastroenterology (1999) 0.87
Familial non-immune hydrops fetalis and congenital pulmonary lymphangiectasia. Eur J Pediatr (1998) 0.85
Familial occurrence of congenital pulmonary lymphangiectasis. Genetic implications. Am J Dis Child (1981) 0.84
Congenital pulmonary lymphangiectasia and other anomalies in a child: provisionally unique syndrome? Am J Med Genet (1996) 0.84
Persistence of müllerian derivatives, lymphangiectasis, hepatic failure, postaxial polydactyly, renal and craniofacial anomalies. Am J Med Genet (1993) 0.84
Persistence of Müllerian derivatives and intestinal lymphangiectasis in two newborn brothers: confirmation of the Urioste syndrome. Am J Med Genet (2001) 0.83
Lymphangiectasia with persistent Müllerian derivatives: confirmation of autosomal recessive Urioste syndrome. Am J Med Genet (2001) 0.82
Hydrops fetalis. Clin Perinatol (2000) 0.80
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-1992. A full-term newborn boy with chronic respiratory distress. N Engl J Med (1992) 0.80
Diagnosis of interstitial lung disease in children. Paediatr Respir Rev (2004) 0.80
Children with congenital pulmonary lymphangiectasia: after infancy. AJR Am J Roentgenol (1999) 0.79
Primary pulmonary lymphangiectasis in a premature infant: resolution following intensive care. Pediatr Pulmonol (2003) 0.79
Molecular regulation of lymphangiogenesis. Ann N Y Acad Sci (2004) 0.79
Mandibulofacial dysostosis or bilateral hemifacial microsomia with hearing loss, telecanthus, tetramelic postaxial hexadactyly, congenital hypotonia and lymphedema with joint hypermobility, and pigmentary dysplasia: a new syndrome? Am J Med Genet (1989) 0.78
Congenital pulmonary lymphangiectasia. Pediatr Pulmonol (1991) 0.78
Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia. Am J Med Genet A (2006) 0.77
Lymphoscintigraphic evaluation of congenital lymphedema of the newborn. Clin Nucl Med (2002) 0.77
Congenital pulmonary lymphangiectasia. N Engl J Med (2004) 0.77
Congenital pulmonary lymphangiectasis. Clin Pediatr (Phila) (2003) 0.77
Congenital pulmonary lymphangiectasia presenting as nonimmune fetal hydrops and severe respiratory distress at birth: not uniformly fatal. Pediatr Pulmonol (2005) 0.77
Congenital pulmonary lymphangiectasis. A case complicated by chylothorax. Clin Pediatr (Phila) (1983) 0.77
Pulmonary lymphangiectasis in an asymptomatic adult. Respiration (2005) 0.77
Hidden pathologies associated with (and concealed by) early gestational isolated fetal hydrothorax. J Pediatr Surg (2005) 0.76
Pulmonary lymphangiectasia. Lymphology (2005) 0.76
[Congenital pulmonary lymphangiectasia revealed by cardiac arrest]. Arch Pediatr (2003) 0.76
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol (2009) 6.51
Diagnosis and management of primary chylous ascites. J Vasc Surg (2006) 1.72
Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clin Chem Lab Med (2007) 1.44
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis. Lancet Oncol (2006) 1.44
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study. Oncology (2005) 1.41
Current views on diagnostic approach and treatment of lymphedema. Am J Med (2012) 1.21
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. J Immunol (2011) 1.11
Evolution of chylous fistula management after neck dissection. Curr Opin Otolaryngol Head Neck Surg (2013) 1.06
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial. J Natl Cancer Inst (2011) 1.05
Microsurgery for lymphedema: clinical research and long-term results. Microsurgery (2010) 1.05
Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A (2009) 1.00
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death. BMC Cancer (2012) 0.98
Pemetrexed for the treatment of non-small cell lung cancer. Expert Opin Pharmacother (2013) 0.96
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine. Curr Drug Targets (2015) 0.95
Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol Rep (2006) 0.93
Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am J Med Genet A (2003) 0.92
The lymphatics in the pathophysiology of thoracic and abdominal surgical pathology: immunological consequences and the unexpected role of microsurgery. Microsurgery (2007) 0.92
The medical oncologist's role in palliative care: AIOM's position. Tumori (2010) 0.91
The application of atmospheric pressure matrix-assisted laser desorption/ionization to the analysis of long-term cryopreserved serum peptidome. Anal Biochem (2011) 0.90
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Target Oncol (2014) 0.90
Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. Ann Plast Surg (2013) 0.88
Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast. J Proteomics (2013) 0.88
Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery (2007) 0.87
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol (2009) 0.87
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunol Immunother (2013) 0.86
Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol (2008) 0.85
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. Future Oncol (2013) 0.85
Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg (2004) 0.84
Diagnostic assessment and therapeutic approach for immunodeficiency due to chylous dysplasia: A case report. Microsurgery (2010) 0.84
Ten novel mutations in the human neurofibromatosis type 1 (NF1) gene in Italian patients. Hum Mutat (2002) 0.83
Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer. J Cancer Res Clin Oncol (2006) 0.83
Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol (2011) 0.82
Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res (2005) 0.82
A diagnostic flow chart for non-immune hydrops fetalis. Am J Med Genet A (2009) 0.82
Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: a case report and review of the literature. Tumori (2013) 0.81
X-linked creatine transporter deficiency: clinical description of a patient with a novel SLC6A8 gene mutation. Neurogenetics (2005) 0.81
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. Breast Cancer Res Treat (2010) 0.81
Lymphatic complications in surgery: possibility of prevention and therapeutic options. Updates Surg (2012) 0.81
Primary bladder angiosarcoma with no apparent previous exposure to carcinogens: a case report. Anal Quant Cytopathol Histpathol (2013) 0.81
Prognostic value of nuclear matrix protein expression in localized prostate cancer. J Cancer Res Clin Oncol (2012) 0.81
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. Anticancer Res (2005) 0.80
Afatinib for the treatment of advanced non-small-cell lung cancer. Expert Opin Pharmacother (2014) 0.80
Neurinoma originating from the recurrent nerve: report of a case. Surg Today (2008) 0.80
Oral vinorelbine in the treatment of non-small-cell lung cancer. Expert Opin Pharmacother (2014) 0.80
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat (2011) 0.79
Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines. Prostate (2011) 0.79
Prostatic and urothelial metastasis in the same lymph node: a case report. Anal Quant Cytopathol Histpathol (2015) 0.78
Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol (2008) 0.78
Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am J Med Genet A (2008) 0.78
Microsurgery for groin lymphocele and lymphedema after oncologic surgery. Microsurgery (2013) 0.78
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer. Future Oncol (2014) 0.78
Endothelial cells increase the radiosensitivity of oropharyngeal squamous carcinoma cells in collagen gel. Oral Oncol (2004) 0.78
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines. Anticancer Res (2013) 0.77
Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia. Am J Med Genet A (2006) 0.77
Lymphoscintigraphic evaluation of congenital lymphedema of the newborn. Clin Nucl Med (2002) 0.77
Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. Expert Opin Biol Ther (2014) 0.77
Safety of antiandrogen therapy for treating prostate cancer. Expert Opin Drug Saf (2014) 0.77
Use of metronomic chemotherapy in oncology: results from a national Italian survey. Tumori (2011) 0.77
Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. Clin Exp Metastasis (2012) 0.77
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era. Int J Hematol (2010) 0.77
Immunohistochemistry in non-immune hydrops fetalis: a single center experience in 79 fetuses. Am J Med Genet A (2010) 0.77
Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer. Future Oncol (2013) 0.76
Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index. Anticancer Res (2009) 0.76
Pediatric lymphedema and correlated syndromes: role of microsurgery. Microsurgery (2008) 0.76
Belagenpumatucel-L for the treatment of non-small cell lung cancer. Expert Opin Biol Ther (2015) 0.76
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy. Lung Cancer (2013) 0.76
Effects of bicalutamide and 4OH-tamoxifen on androgen-regulated gene expression in the LNCaP cell line. Anticancer Res (2012) 0.76
Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected]. Hum Mutat (2003) 0.75
Surgical treatment for lymphedema: optimal timing and optimal techniques. J Am Coll Surg (2013) 0.75
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma. J Thorac Oncol (2015) 0.75
Microsurgical primary prevention of lymphatic injuries following breast cancer treatment. Plast Reconstr Surg (2012) 0.75
Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer. Int J Gynecol Cancer (2013) 0.75
Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature. BMC Cancer (2014) 0.75
Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery (2014) 0.75
Reconstructive microsurgery for lymphedema: while the early bird catches the worm, the late riser still benefits. J Am Coll Surg (2013) 0.75
Efficacy of motesanib diphosphate in non-small-cell lung cancer. Expert Opin Pharmacother (2014) 0.75
Nocturia: an uncommon presentation of lower-limb lymphedema. Am J Med (2010) 0.75
Vulvar sebaceous hyperplasia associated with lymphedema of external genitalia. Int J Dermatol (2010) 0.75
Gynaecomastia: the anastrozole paradox. J Pediatr Endocrinol Metab (2010) 0.75
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report. Tumori (2015) 0.75